A new way to target the ferroptosis regulator GPX4

Brent R. Stockwell, Ph.D.
1 min readNov 23, 2022

--

Today my lab published a paper in Cell Chemical Biology describing a new way of targeting the central regulator of ferroptosis — the lipid repair enzyme glutathione peroxidase 4 (GPX4).

Here is the paper, with free download for the next 50 days:

https://authors.elsevier.com/a/1g8458jWWJpk2b

In short, we found a new site on this protein at cysteine 66 that can be targeted with electrophilic small molecules. We solved numerous high resolution x-ray structures of different compounds bound to this site, revealing how even better compounds can be designed.

Here is what the site looks like:

From the big picture perspective, this is exciting to us because GPX4 is essential in some of the more aggressive and otherwise drug-resistant cancers. Our new paper suggests a strategy for treating these aggressive, drug-resistant cancers. There is still a long way to go to create a drug that acts through this mechanism, of course, but this opens a door to a new strategy. I hope you enjoy reading.

I was happy to see that our paper was highlighted on the cover of the Dec 15th issue of Cell Chemical Biology!

https://www.cell.com/ccbio/issue?pii=S2451945621X0013X#closeFullCover

Please feel free to comment below.

--

--

Brent R. Stockwell, Ph.D.
Brent R. Stockwell, Ph.D.

Written by Brent R. Stockwell, Ph.D.

Chair and Professor of Biological Sciences at Columbia University. Top Medium writer in Science, Creativity, Health, and Ideas

Responses (2)